Inhibrx Biosciences Insider Trades

INBX

Track insider trading activity from Inhibrx Biosciences executives and directors. See which insiders are buying and selling INBX stock.

Trades Last 12 Months

INBX Price

All Insider Trades for Inhibrx Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Matly David President
Holding Value $4.76M 50,000 shares
Last Trade
Apr 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.45M 50,000 shares
$129.06
$95.22
Holding Value $121M 1,267,823 shares
Last Trade
Oct 07, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.3M 350,000 shares
$32.25
$95.22
Manhard Kimberly Director
Holding Value $1.43M 15,000 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 15,000 shares
$12.91
$95.22
Holding Value $1.43M 15,000 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 15,000 shares
$12.91
$95.22
Forsyth Douglas Director
Holding Value $1.43M 15,000 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 15,000 shares
$12.91
$95.22
Kayyem Jon Faiz Director
Holding Value $1.43M 15,000 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 15,000 shares
$12.91
$95.22
Deck Kelly Chief Financial Officer
Holding Value $1.43M 15,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$211k 15,000 shares
$14.05
$95.22
Lappe Mark Chief Executive Officer
Holding Value $67.2M 705,548 shares
Last Trade
Sep 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$223k 13,037 shares
$17.13
$95.22
Eckelman Brendan P. Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 30, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.07M 193,334 shares
$15.86
$95.22
Inhibrx, Inc. 10% owner
Holding Value $110M 1,157,926 shares
Last Trade
May 29, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$454M 13,316,140 shares
$34.11
$95.22
Holding Value $231M 2,427,307 shares
Last Trade
Oct 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40M 1,333,333 shares
$30.00
$95.22
Holding Value $217M 2,274,105 shares
Last Trade
Oct 04, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.11M 40,000 shares
$27.82
$95.22
Wagner Klaus W. Chief Medical Officer
Holding Value $20.5M 215,150 shares
Last Trade
Feb 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$495k 19,559 shares
$25.29
$95.22
Holding Value $0 0 shares
Last Trade
Aug 21, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$75.6M 3,700,634 shares
$20.43
$95.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up